Maj Institute of Pharmacology Polish Academy of Sciences is a consortium member of the GRIEG research project

Maj Institute of Pharmacology Polish Academy of Sciences is a consortium member of the GRIEG research project entitled „Theranostic nanocarriers for drug delivery in central nervous system disorders” funded under the Norwegian Financial Mechanism 2014 – 2021. Prof. Piotr Warszyński from Jerzy Haber Institute of Catalysis and Surface Chemistry PAS is the leader of the project. Apart from IP PAS (Department of Experimental Neuroendocrinology, WP leader Prof. Władysław Lasoń)), other project partners include The Henryk Niewodniczański Institute of Nuclear Physics PAS,  SINTEF AS (Trondheim) and  Oslo University Hospital. The main project objective is to develop a new strategy to deliver neuroprotectants by applying biocompatible theranostic nanocarriers, traceable in vivo by MRI, which can cross the blood-brain barrier without imposing side effects on its normal function. Application of such neuroprotective nanocarriers can be the solution for future therapies of stroke and neurodegenerations like Alzheimer's and Parkinson's diseases.